Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2276217Generated: October 30, 2026

1-(5-Bromothiazol-2-yl)-3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-urea → (5-(2-[3-(2-Cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-5-ylsulfanyl}-tetrazol-1-yl)-acetic acid

https://huagongshe.com/reaction/2276217

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-(5-Bromothiazol-2-yl)-3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureaHCID 59732797—
ReactantHCID 178525857HCID 178525857—
Product(5-(2-[3-(2-Cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-5-ylsulfanyl}-tetrazol-1-yl)-acetic acidHCID 5973303028%

Reaction Steps

(5-{2-[3-(2-Cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-5-ylsulfanyl}-tetrazol-1-yl)-acetic acid (136 mg, 28%) was prepared from 1-(5-bromo-thiazol-2-yl)-3-(2-cyclo pentanecarbonyl-4-methyl-phenyl)-urea (408 mg, 1 mmol) and (5-mercapto-tetrazol-1-yl)-acetic acid (320 mg, 2 mmol) following the general procedure Y.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUSRE045670E1
Source datasetuspto-grants-2015_09
ORD IDord-28a5e5fad9d846a9805f38566c0b94b3
Source noteuspto-grants-2015_09